Symptoms, Diagnosis, and Treatment of Alzheimer's Disease

Prevention, Diagnosis and Treatment of Alzheimer's Disease Alzheimer's disease can become a very uneasy situation for family members and family friends suffering from this disease. According to clinical information, the diagnosis of Alzheimer's disease can be accurately performed in the range of 75% to 97%. These sources use special tools to help test tools for Alzheimer's disease, including "short-term and long-term memory monitoring" (Griffith, 2002). A tool for diagnosing Alzheimer's disease helps to indicate the symptoms that cause the disorder. It affects how people solve problems and solve many other problems that can ultimately be flawed.

Last year, the diagnosis and treatment of Alzheimer's disease (AD) have shifted to the forefront of medical institutions and media. In the spring of 2010, the National Institute of Aging Research (NIA) and the Alzheimer's Disease Association have three working groups to provide advice on changes in memory status, known as AD diagnostic criteria and mild cognitive impairment (MCI) I gathered. In addition to MCI, the working group also proposed to establish a "preclinical Alzheimer's disease" diagnostic category to determine the changes that occurred prior to complete AD diagnosis. These recommendations were announced at the 2010 Alzheimer's Disease Association Alzheimer's International Conference (AAICAD) held in Honolulu in July. The suggested changes can be seen here. However, the Working Group's recommendations on the diagnosis and treatment of AD raised questions in many areas and challenged the working group's conclusions.

For the most part of the 20th century, the diagnosis of Alzheimer's disease was for those with symptoms of dementia between the age of 45 and 65. When AD conference concluded that clinical and pathological signs of Alzheimer's disease and Alzheimer's disease in 1977 are nearly identical, the authors added that this does not rule out the possibility of different causes. This ultimately leads to the diagnosis of Alzheimer's disease regardless of age. The term Alzheimer's type Alzheimer's disease (SDAT) is used to describe the condition of patients over 65 years of age. Classical Alzheimer's disease is used to represent young people. Finally, the term Alzheimer's disease is formally adopted in medical terms and represents individuals of all ages with characteristic common symptom patterns, disease progression, and neuropathology.